Associations between cadmium exposure and circulating levels of sex hormones in postmenopausal women

Environmental Research

Volumn 134, Issue , 2014, Pages 265-269

  Ali, Imran ^a   Engström, Annette ^a   Vahter, Marie ^a   Skerfving, Staffan ^b   Lundh, Thomas ^b   Lidfeldt, Jonas ^b   Samsioe, Göran ^b   Halldin, Krister ^a   Åkesson, Agneta ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Breast cancer; Cadmium; Postmenopausal women; Sex hormones

Indexed keywords

ANDROSTENEDIONE; CADMIUM; CREATININE; ESTRADIOL; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; BIOLOGICAL MARKER; SEX HORMONE;

CADMIUM; CANCER; EPIDEMIOLOGY; HEALTH RISK; HORMONE; POLLUTION EXPOSURE; SEX HORMONE; WOMENS HEALTH; RISK FACTOR;

ADULT; ANDROSTENEDIONE BLOOD LEVEL; ARTICLE; BREAST CANCER; CANCER RISK; CREATININE URINE LEVEL; ENVIRONMENTAL EXPOSURE; ESTRADIOL BLOOD LEVEL; FEMALE; HEAVY METAL BLOOD LEVEL; HORMONE SUBSTITUTION; HUMAN; MIDDLE AGED; NORMAL HUMAN; POSTMENOPAUSE; PRIORITY JOURNAL; SWEDEN; TESTOSTERONE BLOOD LEVEL; URINE LEVEL; ALCOHOL CONSUMPTION; BODY MASS; MAJOR CLINICAL STUDY; SMOKING; BLOOD;

SWEDEN;

CADMIUM; FEMALE; GONADAL STEROID HORMONES; HUMANS; MIDDLE AGED; POSTMENOPAUSE;

EID: 84907379372     PISSN: 00139351     EISSN: 10960953     Source Type: Journal    
DOI: 10.1016/j.envres.2014.08.009     Document Type: Article

References (47)

1. Adams S.V., et al. Dietary cadmium and risk of invasive postmenopausal breast cancer in the VITAL cohort. Cancer Causes Control 2012, 23:845-854.
2. Adams, S.V., et al., 2014. Dietary cadmium exposure and risk of breast, endometrial, and ovarian cancer in the women's health initiative. Environ. Health Perspect.
3. Akerstrom M., et al. The relationship between cadmium in kidney and cadmium in urine and blood in an environmentally exposed population. Toxicol. Appl. Pharmacol. 2013, 268:286-293.
4. Ali I., et al. Estrogen-like effects of cadmium in vivo do not appear to be mediated via the classical estrogen receptor transcriptional pathway. Environ. Health Perspect. 2010, 118:1389-1394.
5. Åkesson A., et al. Long-term dietary cadmium intake and postmenopausal endometrial cancer incidence: a population-based prospective cohort study. Cancer Res. 2008, 68:6435-6441.
6. Åkesson A., et al. Tubular and glomerular kidney effects in Swedish women with low environmental cadmium exposure. Environ Health Perspect. 2005, 113:1627-1631.
7. Barany E., et al. Inductively coupled plasma mass spectrometry for direct multi-element analysis of diluted human blood and serum. J. Anal. Atomic Spectrom. 1997, 12:1005-1009.
8. Byrne C., et al. Cadmium--a metallohormone?. Toxicol. Appl. Pharmacol. 2009, 238:266-271.
9. Byrne C., et al. Metals and breast cancer. J. Mammary Gland Biol. Neoplasia 2013, 18:63-73.
10. Das S., Mukherjee D. Effect of cadmium chloride on secretion of 17beta-estradiol by the ovarian follicles of common carp, Cyprinus carpio. Gen. Comp. Endocrinol. 2013, 181:107-114.
11. Davis J., et al. Effects of maternal dietary exposure to cadmium during pregnancy on mammary cancer risk among female offspring. J. Carcinog. 2013, 12:11.
12. Effenberger K.E., et al. Regulation of osteoblastic phenotype and gene expression by hop-derived phytoestrogens. J. Steroid Biochem. Mol. Biol. 2005, 96:387-399.
13. Eick G.N., Thornton J.W. Evolution of steroid receptors from an estrogen-sensitive ancestral receptor. Mol. Cell. Endocrinol. 2011, 334:31-38.
14. Escande A., et al. Evaluation of ligand selectivity using reporter cell lines stably expressing estrogen receptor alpha or beta. Biochem. Pharmacol. 2006, 71:1459-1469.
15. Feigelson H.S., et al. Sex steroid hormones and genetic susceptibility to breast and prostate cancer. Drug Metab. Rev. 1998, 30:421-434.
16. Gallagher C.M., et al. Environmental cadmium and breast cancer risk. Aging (Albany NY) 2010, 2:804-814.
17. Hankinson S.E., et al. Reproducibility of plasma hormone levels in postmenopausal women over a 2-3-year period. Cancer Epidemiol. Biomark. Prev. 1995, 4:649-654.
18. Hayes T.B., et al. Demasculinization and feminization of male gonads by atrazine: consistent effects across vertebrate classes. J. Steroid Biochem. Mol. Biol. 2011, 127:64-73.
19. IARC A review of human carcinogens-Part C: metals, arsenic, dusts, and fibres. Lancet Oncol. 2009, 10:453-454.
20. Jackson L.W., et al. The association between cadmium, lead and mercury blood levels and reproductive hormones among healthy, premenopausal women. Hum. Reprod. 2011, 26:2887-2895.
21. Johnson M.D., et al. Cadmium mimics the in vivo effects of estrogen in the uterus and mammary gland. Nat. Med. 2003, 9:1081-1084.
22. Julin B., et al. Dietary cadmium exposure and risk of postmenopausal breast cancer: a population-based prospective cohort study. Cancer Res. 2012, 72:1459-1466.
23. Järup L., et al. Health effects of cadmium exposure--a review of the literature and a risk estimate. Scand. J. Work Environ. Health. 1998, 24(Suppl 1):S1-S51.
24. Järup L., Åkesson A. Current status of cadmium as an environmental health problem. Toxicol. Appl. Pharmacol. 2009, 238:201-208.
25. Key T., et al. Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J. Natl. Cancer Inst. 2002, 94:606-616.
26. Key T.J., et al. Sex hormones and risk of breast cancer in premenopausal women: a collaborative reanalysis of individual participant data from seven prospective studies. Lancet Oncol. 2013, 14:1009-1019.
27. Khatibi A., et al. Could androgens protect middle-aged women from cardiovascular events? A population-based study of Swedish women: the Women's Health in the Lund Area (WHILA) Study. Climacteric 2007, 10:386-392.
28. Lidfeldt J., et al. A screening procedure detecting high-yield candidates for OGTT. The Women's Health in the Lund Area (WHILA) study: a population based study of middle-aged Swedish women. Eur. J. Epidemiol. 2001, 17:943-951.
29. Mcelroy J.A., et al. Cadmium exposure and breast cancer risk. J. Natl. Cancer Inst. 2006, 98:869-873.
30. Meldrum D.R., et al. Changes in circulating steroids with aging in postmenopausal women. Obstet. Gynecol. 1981, 57:624-628.
31. Nagata C., et al. Cadmium exposure and the risk of breast cancer in Japanese women. Breast Cancer Res. Treat. 2013, 138:235-239.
32. Nagata C., et al. Urinary cadmium and serum levels of estrogens and androgens in postmenopausal Japanese women. Cancer Epidemiol. Biomark. Prev. 2005, 14:705-708.
33. Persson I. Estrogens in the causation of breast, endometrial and ovarian cancers - evidence and hypotheses from epidemiological findings. J. Steroid Biochem. Mol. Biol. 2000, 74:357-364.
34. Piasek M., Laskey J.W. Acute cadmium exposure and ovarian steroidogenesis in cycling and pregnant rats. Reprod. Toxicol. 1994, 8:495-507.
35. Piasek M., Laskey J.W. Effects of in vitro cadmium exposure on ovarian steroidogenesis in rats. J. Appl. Toxicol. 1999, 19:211-217.
36. Rehm S., Waalkes M.P. Cadmium-induced ovarian toxicity in hamsters, mice, and rats. Fundam. Appl. Toxicol. 1988, 10:635-647.
37. Rohr U.D. The impact of testosterone imbalance on depression and women's health. Maturitas 2002, 41(Suppl 1):S25-S46.
38. Safe S. Cadmium's disguise dupes the estrogen receptor. Nat. Med. 2003, 9:1000-1001.
39. Samsioe G., et al. The women's health in the Lund area (WHILA) study--an overview. Maturitas 2010, 65:37-45.
40. Sawada N., et al. Long-term dietary cadmium intake and cancer incidence. Epidemiology 2012, 23:368-376.
41. Sheehan D.M. Activity of environmentally relevant low doses of endocrine disruptors and the bisphenol A controversy: initial results confirmed. Proc. Soc. Exp. Biol. Med. 2000, 224:57-60.
42. Shelley J.M., et al. Relationship of endogenous sex hormones to lipids and blood pressure in mid-aged women. Ann. Epidemiol. 1998, 8:39-45.
43. Sonneveld E., et al. Comparison of in vitro and in vivo screening models for androgenic and estrogenic activities. Toxicol. Sci. 2006, 89:173-187.
44. Stoica A., et al. Activation of estrogen receptor-alpha by the heavy metal cadmium. Mol. Endocrinol. 2000, 14:545-553.
45. Strumylaite L., et al. Association between cadmium and breast cancer risk according to estrogen receptor and human epidermal growth factor receptor 2: epidemiological evidence. Breast Cancer Res. Treat. 2014, 145:225-232.
46. Vandenberg L.N., et al. Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses. Endocr. Rev. 2012, 33:378-455.
47. Welshons W.V., et al. Large effects from small exposures. I. Mechanisms for endocrine-disrupting chemicals with estrogenic activity. Environ. Health Perspect. 2003, 111:994-1006.